Research summary, systematic review or meta-analysis, 2024

Is Ocular Safety in Orthopedics Overlooked? A Systematic Review of Annual Ocular Radiation Exposure and Protective Measures

Clinical Orthopedics and Related Research. 2024

Read the original paper

In plain language

Across 23 dosimetry studies, most orthopaedic surgeons' eye doses were below the 20 mSv annual limit, though high-volume fluoroscopy users may exceed it. Wrap-around leaded glasses cut eye dose about 90%, and standard mini C-arm setup lowered exposure substantially.

At a glance

Type of study
Systematic review or meta-analysis, Systematic review
Who was studied
Orthopedic surgeons, Phantom or simulation (no people)
Size
n = 23 studies
Summary based on
the abstract

What it found

  • Most orthopaedic surgeons stay below the 20 mSv annual eye dose limit, but those doing many fluoroscopy-intensive procedures may exceed it.

    Key figures: 20 mSv annual limit

  • Leaded eyeglasses cut eye dose by about 90%, with sport wrap-around designs shielding best, yet they were underused.

    Key figures: about 90%

  • Standard vertical mini C-arm configuration lowered exposure up to 13-fold versus inverted configuration; standing perpendicular to the fluoroscope reduced eye dose further.

    Key figures: up to 13-fold decrease

  • Included evidence was heterogeneous dosimetry studies of generally good quality; no meta-analysis was possible.

    Key figures: 23 studies; MINORS 14 ± 0 of 16 and 19 ± 1 of 24

Limits to keep in mind

Narrative synthesis of 23 heterogeneous dosimetry studies, including 8 phantom or cadaver models and only one randomized trial; no meta-analysis and no long-term eye health outcomes.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 5, 2026.